Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: Evidence from 47 published studies

Mutagenesis

Volumn 26, Issue 5, 2011, Pages 637-642

  He, Bangshun ^a   Zhang, Ying ^b   Pan, Yuqin ^a   Xu, Yeqiong ^a   Gu, Ling ^a,c   Chen, Liping ^a,c   Wang, Shukui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Kunshan Hospital of Traditional Chinese Medicine   (China)

^c NANJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA;

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER;

ALLELES; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC HETEROGENEITY; HUMANS; INTERLEUKIN-1BETA; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS; RISK;

EID: 80052305117     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger025     Document Type: Article

References (50)

1. Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature, 420, 860-867.
2. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancerrelated inflammation. Nature, 454, 436-444.
3. Demeter, J., Messer, G., Ramisch, S., Mee, J. B., di Giovine, F. S., Schmid, M., Herrmann, F. and Porzsolt, F. (1996) Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol. Ther., 2, 239-242.
4. McColl, K. E. and El-Omar, E. (2002) How does H. pylori infection cause gastric cancer? Keio J Med, 51 (Suppl. 2), 53-56.
5. El-Omar, E. M., Carrington, M., Chow, W. H. et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, 398-402.
6. Chen, H., Wilkins, L. M., Aziz, N. et al. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet., 15, 519-529.
7. Lind, H., Haugen, A. and Zienolddiny, S. (2007) Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine, 38, 43-48.
8. Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F. and Haugen, A. (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer, 109, 353-356.
9. Liu, J., Zhai, X., Jin, G. et al. (2006) Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: A casecontrol analysis in a Chinese population. Int. J. Cancer,, 118, 2554-2558.
10. Hirankarn, N., Kimkong, I., Kummee, P., Tangkijvanich, P. and Poovorawan, Y. (2006) Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J. Gastroenterol., 12, 776-779.
11. Ito, H., Kaneko, K., Makino, R. et al. (2007) Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol. Rep., 18, 473-481.
12. Hefler, L. A., Ludwig, E., Lebrecht, A., Zeillinger, R., Tong-Cacsire, D., Koelbl, H., Leodolter, S. and Tempfer, C. B. (2002) Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J. Soc. Gynecol. Investig., 9, 386-390.
13. Campa, D., Hung, R. J., Mates, D. et al. (2005) Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 538-539.
14. Hefler, L. A., Grimm, C., Lantzsch, T. et al. (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin. Cancer Res., 11, 5718-5721.
15. Kupcinskas, L., Wex, T., Kupcinskas, J. et al. (2010) Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: A combined haplotype analysis. Eur. J. Gastroenterol. Hepatol., 22, 1189-1195.
16. Vincenzi, B., Patti, G., Galluzzo, S. et al. (2008) Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis. Oncol. Rep., 20, 1213-1220.
17. Kato, S., Onda, M., Yamada, S., Matsuda, N., Tokunaga, A. and Matsukura, N. (2001) Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J. Gastroenterol., 36, 696-699.
18. Yang, J., Hu, Z., Xu, Y. et al. (2004) Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett., 215, 191-198.
19. Hamajima, N., Matsuo, K., Suzuki, T., Nakamura, T., Matsuura, A., Tajima, K. and Tominaga, S. (2001) Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn. J. Cancer Res., 92, 488-493.
20. Wang, Y., Kato, N., Hoshida, Y. et al. (2004) UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection. Clin. Cancer Res., 10, 2441-2446.
21. Zumkeller, N., Brenner, H., Chang-Claude, J., Hoffmeister, M., Nieters, A. and Rothenbacher, D. (2007) Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: Evidence from a case-control study in Germany. Eur. J. Cancer, 43, 1283-1289.
22. Ruzzo, A., Graziano, F., Pizzagalli, F. et al. (2005) Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann. Oncol., 16, 887-892.
23. Tatemichi, M., Sawa, T., Gilibert, I., Tazawa, H., Katoh, T. and Ohshima, H. (2005) Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter. Cancer Lett., 217, 197-202.
24. Handoll, H. H. (2006) Systematic reviews on rehabilitation interventions. Arch. Phys. Med. Rehabil., 87, 875.
25. Midgette, A. S., Wong, J. B., Beshansky, J. R., Porath, A., Fleming, C. and Pauker, S. G. (1994) Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med. Decis. Making, 14, 108-117.
26. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
27. Garza-Gonzalez, E., Bosques-Padilla, F. J., El-Omar, E., Hold, G., Tijerina-Menchaca, R., Maldonado-Garza, H. J. and Perez-Perez, G. I. (2005) Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int. J. Cancer, 114, 237-241.
28. Chen, C. C., Yang, S. Y., Liu, C. J. et al. (2005) Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int. J. Epidemiol., 34, 1310-1318.
29. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Xiao, F., Kajimura, M., Sugimura, H. and Hishida, A. (2007) Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J. Gastroenterol. Hepatol., 22, 51-59.
30. Okamoto, K., Ishida, C., Ikebuchi, Y., Mandai, M., Mimura, K., Murawaki, Y. and Yuasa, I. (2010) The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern. Med., 49, 887-895.
31. Qian, N., Chen, X., Han, S. et al. (2010) Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J. Cancer Res. Clin. Oncol., 136, 709-716.
32. Ennas, M. G., Moore, P. S., Zucca, M. et al. (2008) Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol. Oncol., 26, 98-103.
33. Lewis, A. M., Varghese, S., Xu, H. and Alexander, H. R. (2006) Interleukin-1 and cancer progression: The emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med., 4, 48.
34. Landvik, N. E., Hart, K., Skaug, V., Stangeland, L. B., Haugen, A. and Zienolddiny, S. (2009) A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis, 30, 1186-1192.
35. Huang, Y. T., Liu, M. Y., Tsai, C. H. and Yeh, T. H. (2010) Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth. Head Neck, 32, 869-876.
36. Chang, Y. W., Jang, J. Y., Kim, N. H. et al. (2005) Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer, 114, 465-471.
37. Hulkkonen, J., Vilpo, J., Vilpo, L., Koski, T. and Hurme, M. (2000) Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: Correlation with prognostic parameters. Haematologica, 85, 600-606.
38. zur Hausen, A., Crusius, J. B., Murillo, L. S., Alizadeh, B. Z., Morre, S. A., Meijer, C. J., van den Brule, A. J. and Pena, A. S. (2003) IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma. Int. J. Cancer, 107, 866-867.
39. Yeo, A. E., Tanaka, Y. and Furuta, T. (2003) Interleukin 1beta gene polymorphism and hepatitis C virus-related hepatocellular carcinoma. Hepatology, 38, 267-268; author Reply, 268-269.
40. Sakuma, K., Uozaki, H., Chong, J. M., Hironaka, M., Sudo, M., Ushiku, T., Nagai, H. and Fukayama, M. (2005) Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection. Int. J. Cancer, 115, 93-97.
41. Wang, S. K., Zhu, H. F., He, B. S., Zhang, Z. Y., Chen, Z. T., Wang, Z. Z. and Wu, G. L. (2007) CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis. World J. Gastroenterol., 13, 2923-2931.
42. Li, C., Xia, H. H., Xie, W., Hu, Z., Ye, M., Li, J., Cheng, H., Zhang, X. and Xia, B. (2007) Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J. Gastroenterol. Hepatol., 22, 234-239.
43. Xuan, J., Deguchi, R., Watanabe, S. et al. (2005) Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection. J. Gastroenterol., 40, 796-801.
44. Gehmert, S., Velapatino, B., Herrera, P. et al. (2009) Interleukin-1 beta single-nucleotide polymorphism's C allele is associated with elevated risk of gastric cancer in Helicobacter pylori-infected Peruvians. Am. J. Trop. Med. Hyg., 81, 804-810.
45. Dinarello, C. A. (1996) Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147.
46. Tirona, M. T., Sehgal, R. and Ballester, O. (2010) Prevention of breast cancer (part I): Epidemiology, risk factors, and risk assessment tools. Cancer Invest., 28, 743-750.
47. Willett, W. (1989) The search for the causes of breast and colon cancer. Nature, 338, 389-394.
48. Press, D. J. and Pharoah, P. (2010) Risk factors for breast cancer: A reanalysis of two case-control studies from 1926 and 1931. Epidemiology, 21, 566-572.
49. Speirs, V., Kerin, M. J., Newton, C. J., Walton, D. S., Green, A. R., Desai, S. B. and Atkin, S. L. (1999) Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells. Int. J. Oncol., 15, 1251-1254.
50. Ito, L. S., Iwata, H., Hamajima, N. et al. (2002) Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT/TT relative to CC genotype. Jpn. J. Clin. Oncol., 32, 398-402.